The Patient Protection and Affordable Care Act adds a new provision to the Internal Revenue Code that could provide a significant benefit to small and mid-size companies in the biotechnology industry. The Act, which was signed by President Obama on March 23, authorizes the Secretary of the Treasury to award up to $1 billion in qualifying therapeutic discovery project credits in 2009 and 2010. The credit is equal to 50% of an eligible taxpayer’s qualified investment in a qualifying therapeutic discovery project.
Qualifying therapeutic discovery projects include projects that are designed to treat, prevent, or diagnose diseases or conditions, as well as projects designed to develop products, processes or technologies to further the delivery or administration of therapeutics. Taxpayers must apply to receive the credit, and any taxpayer with 250 or fewer employees is eligible to submit an application. In lieu of the tax credit, eligible taxpayers can apply for a grant equal to 50% of the taxpayer’s qualified investment.
The Act requires the Secretary of the Treasury, in conjunction with the Department of Health and Human Services, to establish a program to consider and certify qualified investments no later than May 21, 2010. Therefore, regulations detailing the required form and content of the credit and grant applications will likely be released in mid-May. In the meantime, there are several steps that taxpayers in the biotech industry could take to prepare for the application process, including evaluating current and planned projects to determine which projects could qualify for the credit and itemizing qualified investment expenses.
For detailed information about the credit, click here.
For media coverage on the topic, click here.
- Partner
Mark Sims practices in the Business Representation & Transactions Group and works primarily in the federal income tax, business planning and healthcare areas. Mark's federal tax practice involves individual, corporate, S ...
- Partner
Mike Moeddel is a trusted advisor to senior executives and investors on key strategic transactions including mergers and acquisitions, private equity investments, equity and debt financing transactions and other commercial ...
Topics/Tags
Select- Securities Law
- SEC
- Tax Planning
- Corporate Tax
- Coronavirus
- Securities Regulation
- Nasdaq
- Taxation
- Corporate Law
- Paycheck Protection Program
- Private Offerings
- IRS
- Dodd-Frank
- Proxy Access Rules
- Securities Litigation
- FAST Act
- JOBS Act
- Cryptocurrency
- Cybersecurity and Privacy Law
- SEC Enforcement
- Hedging
- Crowdfunding
- Consumer Protection Act
- Ohio LLC Act
- Corporate Governance
- Real Estate Law
- Intellectual Property
- Technology
- Emerging Growth Companies
- Investors
- Conflict Minerals
- Opportunity Zone
- LIBOR
- Pay Ratio Disclosure
- Whistleblower
- Mergers & Acquisitions
- Accredited Investors
- Sales Tax
- United States Supreme Court
- Online Trading Platforms
- Litigation
- IPO
- Registration Statement
- Annual Reports
- Executive Compensation
- Health Care Act
- Ohio Foreclosure Reform
- Family-Controlled Entities
- Gift and Estate Transfers
- Director Compensation
- Board of Directors
- Director Independence
- Wall Street Reform
- Clawback Rules
- Total Shareholder Return
- Cyber Insurance
- Data Breach
- Lenders
- Receivership Statute
- Regulation A
- Regulation D
- Business Process Improvement
- Employer Policies
- Employment Litigation
- Labor & Employment Law
- Labor Law
- Sixth Circuit
- Compensation Committee Certification
- Government Shutdown
- CDEs
- CDFI Fund
- Community Development Entities
- Community Development Financial Institutions Fund
- New Markets Tax Credit
- NMTC
- NMTC Financing
- Regulation Fair Disclosure
- Social Media
- Marketing
- Benefits
- Healthcare Reform
- Public Company Transition Rules
- Employment Incentives
- HIRE Act
- Social Security Tax
- Tax Credit
Recent Posts
- Stimulus Package Reverses IRS’s Position on Deductibility of PPP Expenses and Other Loan Forgiveness Issues
- Nasdaq Proposes New Listing Rules to Advance Board Diversity: Comply or Explain
- More Disclosure Modernization: SEC Adopts Significant Amendments to Financial Disclosure Rules
- SEC Eases Limits and Rules on Private Offerings
- SEC Proposes Conditional Exemption for "Finders" Involved in Capital Raising
- Ohio Adopts Protections for Ohio Businesses from Coronavirus - Related Lawsuits
- SEC Scales Back Financial Disclosures for Business Combinations
- State of Ohio Issues Urgent Health Advisory and Partial Rescission of “Stay at Home” Order
- SEC Adopts Temporary Rules to Expedite Regulation Crowdfunding Offerings Amid COVID-19 Pandemic
- Treasury Releases PPP Loan Forgiveness Application